RSLS

ReShape Lifesciences® Regains Compliance With Nasdaq Minimum Stockholders Equity Requirement

时间：2025-06-27 21:01:00 市场： 美股 综合

关联： RSLS

ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

时间：2025-06-26 20:31:00 市场： 美股 综合

关联： RSLS

ReShape Lifesciences Inc - Announces Workforce Reduction to Save Over $750K Annually

时间：2025-06-26 20:31:00 市场： 美股 综合

关联： RSLS

ReShape Lifesciences Inc - Prices Public Offering of 2,575,107 Units at $2.33 per Unit

时间：2025-02-16 12:17:55 市场： 美股 综合

关联： RSLS

ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering

时间：2025-02-16 12:17:55 市场： 美股 综合

关联： RSLS

ReShape Lifesciences Inc - Receives Notice of Non-Compliance From Nasdaq

时间：2024-12-03 05:09:20 市场： 美股 综合

关联： RSLS

ReShape Lifesciences Announces 1-for-58 Reverse Stock Split

时间：2024-09-19 20:31:00 市场： 美股 综合

关联： RSLS